UNSPSC 51392221: Detomidine hydrochloride for veterinary use

This classification denotes an alpha-adrenergic agonist with the molecular formula C12H14N2.ClH, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 95K4LKB6QE, chemically known as 4-((2,3-dimethylphenyl)methyl)-1h-imidazole hydrochloride but more generally known as detomidine hydrochloride, which bears US NIH Compound Identifier 56031. European Medicines Agency schedules Detomidine hydrochloride for veterinary use in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB11892MIG.

Most nations, for tariff and trade purposes, schedule detomidine hydrochloride for veterinary use under HS 29332990. SMILES: CC1CCCC(C1C)CC2C[NH]CN2.CL.

UNSPSC 51392221 Detomidine hydrochloride for veterinary use is a Commodity code that shows minimal alignment with actual state and local procurement activity. The recent opportunities posted under this code concern naloxone procurement and direct-to-manufacturer prescription programs—neither of which involves detomidine hydrochloride or veterinary pharmaceuticals. Detomidine is a sedative used exclusively in equine and small-animal veterinary medicine, yet the state and local opportunities tagged to this code address human-use opioid antagonists and pharmacy benefit management strategies for state employee health plans. The code's nominal scope and the work actually being solicited diverge fundamentally, suggesting either miscategorization in the state and local procurement systems or incidental tagging that does not reflect true market demand.

The Seminole County, Florida IFB (IFB60459723LAS, due July 26, 2023) sought 1,900 units of naloxone and 800 safe drug deactivation systems annually for community health initiatives, while the Texas Health and Human Services Commission RFI (HHS0017013, posted April 3, 2026) gathered market intelligence on direct contracting between state pharmacy benefit programs and pharmaceutical manufacturers. Neither solicitation relates to veterinary pharmaceutical supply or equine sedation products. State and local procurement activity under this code appears negligible for vendors targeting detomidine hydrochloride supply to veterinary providers, government animal facilities, or research institutions.